RNS Number : 8700V
Plant Health Care PLC
10 July 2024
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Full name of discloser:

Plant Health Care plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

    

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

    

Plant Health Care plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

    

8 July 2024

(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

    

N/A

 

2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of 1p each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Nil

Nil

Nil

(2) Cash-settled derivatives:

 

Nil

Nil

Nil

Nil

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Nil

Nil

Nil

 

     TOTAL:

Nil

Nil

Nil

Nil

 

 

(b)        Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a)  Interests in Plant Health Care PLC's ordinary shares of 1p each held by the directors of Plant Health Care plc:

 

Name

Number of Ordinary Shares

% of issued share capital

Dr Christopher Richards

5,702,849

1.66%  

Jeffrey Tweedy

1,958,341

0.57%

Jeffrey Hovey

1,059,854

0.31%

William Lewis

940,951

0.27%




Total

9,661,995

2.83%

 

(b)  Rights to subscribe for Interests in Plant Health Care PLC's ordinary shares of 1p each held by the directors of Plant Health Care plc:

 

PHC Director

Award Type*

 

Number of PHC Shares Awards

Date(s) of grant

Vesting

Exercise price (£)

Expiration date

Jeffrey Hovey

Plan

820,793

14.11.2019

14.11.2019

0.085

14.11.2029

Plan

823,096***

08.06.2020

08.06.20

0.10

08.06.2025

Plan

234,146***

24.06.2020

24.06.20

0.10

24.06.2030

Plan

354,545

06.10.2020

06.10.2022 **See below

0.01

06.10.2025

Plan

700,000

23.07.2021

23.07.2023

**See below

0.01

23.07.2026

Plan

1,500,000

11.08.2022

11.08.2024

**See below

0.01

11.08.2027

Plan

401,000

19.12.2023

19.12.2025

**See below

0.01

19.12.2028

Total

4,833,580





Jeffrey Tweedy

Plan

1,422,709

14.11.2019

14.11.2019

0.085

14.11.2029

Plan

983,487***

08.06.2020

08.06.20

0.10

08.06.2025

Plan

380,488***

24.06.2020

24.06.20

0.10

24.06.2030

Plan

354,545

06.10.2020

06.10.2022 **See below

0.01

06.10.2025

Plan

1,000,000

23.07.2021

23.07.2023

**See below

0.01

23.07.2026

Plan

3,000,000

11.08.2022

11.08.2024

**See below

0.01

11.08.2027

Plan

532,000

19.12.2023

19.12.2025

**See below

0.01

19.12.2028

Total

7,673,229





Dr Christopher Richards

Plan

2,691,022***

08.06.2020

08.06.20

0.10

08.06.2025

Plan

975,000

06.10.2020

06.10.2022 **See below

0.01

06.10.2025

Plan

3,000,000

23.07.2021

23.07.2023

**See below

0.01

23.07.2026

Plan

2,000,000

11.08.2022

11.08.2024

**See below

0.01

11.08.2027

Total

8,666,022





 

\* These options were awarded under the Company's 2017 Employee Share Option Plan (the "Plan") on the dates shown in the table above.

** On the earlier of a change of control in the ownership of the Company, or the satisfaction of the Performance / Service Based Requirement, and for United States employees no option shall be exercised before the two-year anniversary of the date of grant.

***indicates PHC Share Awards which are not expected to be exercised prior to the Effective Date on the basis that the exercise price is greater than the offer price.

 

 

4.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

 

 

None

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

 

 

None

 

 

(c)        Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

No

Supplemental Form 8 (SBL)

No

 

 

Date of disclosure:

4 Jul 2024

Contact name:

Jeffrey Tweedy

Telephone number:

+1 919 926 1600

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEANXEFDSLEEA